Literature DB >> 7693778

Sweat gland adenomas: immunohistochemical study with emphasis on myoepithelial differentiation.

E L Wiley1, S Milchgrub, R G Freeman, E S Kim.   

Abstract

Thirty-one dermal appendage tumors of sweat gland differentiation including 7 spiradenomas (SPA), 8 cylindromas (CYL), 8 acrospiromas (ACS), and 8 chondroid syringomas (CS) were analyzed using antibodies to epithelial membrane antigen (EMA), cytokeratin (AE1, AE3, CAM 5.2, 34BE12), S-100 protein, actin (ACT), and desmin (DES) to characterize the immunocytochemical profile of benign sweat gland tumors. Cytokeratin expression was variable; AE1, 34BE12, AE3, and CAM 5.2 were present in 31, 24, 23, and 22 tumors respectively; 29 tumors contained EMA. Seventeen tumors, (6 SPA, 8 CYL, 2 ACS, 1 CS) stained with antibody to alpha smooth muscle actin, and 26 (7 SPA, 7 CYL, 4 ACS, 8 CS) expressed S-100 protein. Although some prior studies had reported actin filaments on electron microscopy in both spiradenoma and cylindroma, these tumors have previously been considered to be negative for myoepithelial differentiation. All spiradenomas and cylindromas we studied demonstrated actin and/or S-100 protein positivity in basal epithelial cells, consistent with myoepithelial differentiation. The organization of actin and S-100 protein positivity displayed by the spiradenomas and cylindromas we studied suggests that the tumors are differentiated towards the secretory portion of the eccrine sweat gland.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7693778     DOI: 10.1111/j.1600-0560.1993.tb01272.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  2 in total

1.  Giant vascular eccrine spiradenoma.

Authors:  Min Ho Kim; Eujin Cho; Jeong Deuk Lee; Sang Hyun Cho
Journal:  Ann Dermatol       Date:  2011-10-31       Impact factor: 1.444

2.  Immunohistochemical and electron microscopic studies of Langerhans cells in a case of multiple eccrine spiradenomas.

Authors:  Yuji Ohtsuki; Hisashi Ohtsuka; Atsushi Kurabayashi; Mitsuko Iguchi; Manabu Matsumoto; Tamotsu Takeuchi; Gang-Hong Lee; Mutsuo Furihata
Journal:  Med Mol Morphol       Date:  2007-12-21       Impact factor: 2.309

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.